YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.

Press Releases YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

Equities

1558

CNE1000023R6

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-04-26 am EDT			5-day change	1st Jan Change
12.8 ^HKD	+2.40%		+3.56%	+34.88%

Apr. 09	Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma	MT
Apr. 01	Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

YiChang HEC ChangJiang Pharmaceutical : ANNOUNCEMENT PROFIT WARNING	21-08-20	PU
YiChang HEC ChangJiang Pharmaceutical : VOLUNTARY ANNOUNCEMENT FEBUXOSTAT TABLETS APPROVED TO LAUNCH	21-05-14	PU
YiChang HEC ChangJiang Pharmaceutical : ANNOUNCEMENT ON FINANCIAL INFORMATION FOR THE FIRST QUARTER OF 2021	21-04-29	PU
YiChang HEC ChangJiang Pharmaceutical : FURTHER DELAY IN DESPATCH OF CIRCULAR IN RELATION TO CONTINUING CONNECTED TRANSACTIONS AND CONNECTED TRANSACTION	21-04-29	PU
YiChang HEC ChangJiang Pharmaceutical : VOLUNTARY ANNOUNCEMENT	21-04-19	PU
YiChang HEC ChangJiang Pharmaceutical : Form of Proxy for the 2021 First H Shareholders Class Meeting to be held on 4 June 2021	21-04-15	PU
YiChang HEC ChangJiang Pharmaceutical : Form of Proxy for the Annual General Meeting to be held on 4 June 2021 (or any adjournment thereof)	21-04-15	PU
YiChang HEC ChangJiang Pharmaceutical : NOTICE OF 2021 FIRST H SHAREHOLDERS CLASS MEETING	21-04-15	PU
YiChang HEC ChangJiang Pharmaceutical : 2020 Report of the Board of Directors 2020 Report of the Board of Supervisors 2020 Consolidated Financial Statements 2020 Annual Report Re-appointment of the Auditor of the Company Proposed Election of Directors of the 3rd Session of the Board of Directors Proposed Election of Shareholder Representative Supervisors of the 3rd Session of the Board of Supervisors General Mandate to Issue Shares, Repurchase H Shares Notice of AGM and Notice of 2021 First H Shareholders C	21-04-15	PU
YiChang HEC ChangJiang Pharmaceutical : DELAY IN DESPATCH OF CIRCULAR IN RELATION TO DISCLOSEABLE AND CONNECTED TRANSACTIONS REGARDING AMENDMENTS TO THE NON-COMPETITION AGREEMENT	21-04-15	PU
YiChang HEC ChangJiang Pharmaceutical : DELAY IN DESPATCH OF CIRCULAR IN RELATION TO CONTINUING CONNECTED TRANSACTIONS AND CONNECTED TRANSACTION	21-04-08	PU
YiChang HEC ChangJiang Pharmaceutical : VOLUNTARY ANNOUNCEMENT ENTACAPONE TABLETS APPROVED TO LAUNCH	21-04-07	PU
YiChang HEC ChangJiang Pharmaceutical : DISCLOSEABLE TRANSACTIONS AND CONTINUING CONNECTED TRANSACTIONS, CONTINUING CONNECTED TRANSACTIONS AND CONNECTED TRANSACTIONS	21-03-21	PU
YiChang HEC ChangJiang Pharmaceutical : DISCLOSEABLE AND CONNECTED TRANSACTIONS AMENDMENTS TO THE NON-COMPETITION AGREEMENT	21-03-19	PU
YiChang HEC ChangJiang Pharmaceutical : ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2020; AND CHANGE OF BUILDING NAME OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG	21-03-19	PU
YiChang HEC ChangJiang Pharmaceutical : PROPOSED ELECTION OF DIRECTORS OF THE THIRD SESSION OF THE BOARD OF DIRECTORS AND PROPOSED ELECTION OF SUPERVISORS OF THE THIRD SESSION OF THE BOARD OF SUPERVISORS	21-03-19	PU
YiChang HEC ChangJiang Pharmaceutical : INSIDE INFORMATION ANNOUNCEMENT ON WAIVER OF PRE-EMPTIVE RIGHT	21-03-19	PU
YiChang HEC ChangJiang Pharmaceutical : VOLUNTARY ANNOUNCEMENT SUBMISSION OF REGISTRATION FOR DOMESTIC PRODUCTION OF INSULIN ASPART INJECTION HAVING BEEN ACCEPTED	21-03-01	PU
YiChang HEC ChangJiang Pharmaceutical : PROGRESS OF COMPLETION OF H SHARE FULL CIRCULATION	20-09-16	PU
YiChang HEC ChangJiang Pharmaceutical : VOLUNTARY ANNOUNCEMENT LETTER OF INTENT IN RESPECT OF NATIONAL COLLABORATIVE INNOVATION INDUSTRIALIZATION PLATFORM FOR DRUGS OF EMERGENCY PREVENTION AND CONTROL CUM NATIONAL ANTIVIRAL DRUG CENTRE	20-08-24	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

Equities

1558

CNE1000023R6

Press Releases

Filters